# A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain

> **NCT00414466** · PHASE2 · TERMINATED · sponsor: **MedtronicNeuro** · enrollment: 254 (actual)

## Conditions studied

- Chronic Intractable Pain

## Interventions

- **DRUG:** Intraspinal Gabapentin

## Key facts

- **NCT ID:** NCT00414466
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2009-12
- **Final completion:** 2010-08
- **Target enrollment:** 254 (ACTUAL)
- **Why stopped:** Study closed and subject follow-up completed following analysis of blinded study data.
- **Last updated:** 2013-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414466, "A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00414466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*